英博博士是苏州艾博生物的创始人兼首席执行官，并当选2019苏州工业园区及姑苏领军人才、2020江苏省双创人才。英博博士具有多年的创新药研发经验，创立艾博生物之前，曾任职于美国多家上市医药公司，是核酸药物纳米制剂和工业化生产方面的专家，其在美国申报的IND涵盖小核酸，信使核糖核酸及基因编辑类药物且均已进入临床评估阶段。
英博博士获得复旦大学生命科学学士及神经生物学硕士学位，美国波士顿东北大学药剂学博士学位。

Dr. Ying is the founder and CEO of Suzhou Abogen Biosciences. He has more than 10 years of experiences in nucleic acid-based therapeutics and has served as scientific leader and research director in multiple pharmaceutical companies in Boston.
Dr. Ying received his bachelor’s degree in life sciences and master’s degree in neuroscience from Fudan University, Shanghai, China, and a Ph.D. degree in pharmaceutical sciences from Northeastern University.